The Palmer Foundation
We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant. The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.
Dr. Richard Urso is a medical doctor and scientist who invented an FDA approved wound healing drug. With a background in drug development, he has been advocate for early treatment since March 2020. He’s appeared on over 60 media outlets including Laura Ingraham, Charlie Kirk, and C span. He’s met with leaders of the Covid task force such as Vice President Pence, Deborah Birx, leaders of the Congress, Senate and CDC. He’s played a prominent role in Covid awareness in Texas, meeting with members of the Governor’s office and testifying before the Texas Senate.
There are a number of protocols (sets of prescription and/or OTC meds) for COVID-19. There are prophylactic protocols, which reduce risk of infection. There are sick-at-home protocols, for the milder cases. And there are in-hospital protocols, for the more severe cases.
Risk and benefit analysis suggests if a drug with a well-established, safe profile can help then why wouldn’t such a drug be used?
The latest information about:
the Delta variant;
asymptomatic transmission and testing;
natural immunity from having a covid-19 infection vs vaccination;
what to do if you have symptoms;
testing;
the use of nutraceuticals;
treatment protocols;
the use of hydroxychloroquine and ivermectin;
putting to rest the question of hydroxychloroquine and adverse cardiological effects;
gastrointestinal symptoms of Delta;
being aware of our state of health;
oral and dental hygiene;
the use of monoclonal antibodies including Regeneron, Remdesivir and full dose blood thinners;
outpatient followup;
long hauler Covid;
myocarditis;
the commencement of early treatment;
the role of fever in the disease process;
the use of NSAIDs;
obesity as a risk factor;
talking to your physician;
the failure of vaccines.
An in-depth interview with Dr. Tess Lawrie of EBMC Squared describing the effectiveness of long-time safe medicine ivermectin to treat and prevent covid and how health authorities are systematically ignoring the evidence.
In Dr. Ozaki’s recent speech, he declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. The head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.
Just as Galileo proved with his telescope that the earth was NOT the center of the Universe in 1616; today, the data from India shows that Ivermectin is effective, much more so than the vaccines. It not only prevents death, but it also prevents COVID infections, and it also is effective against the Delta Variant.
Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.
Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed existing drugs for the early treatment of
covid-19. One such drug is Ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. properties as well. E-BMC Ltd’s comprehensive meta-analysis, which has now been published in the peer-reviewed American Journal of Therapeutics, shows that “moderate-certainty evidence” points to a substantial reduction in Covid-19 related deaths with the use of ivermectin.
Dr George Fareed provides an update about the outpatient treatment of COVID-19, for newly infected and for long covid patients.
Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.
The heated debate on the use of Ivermectin to treat COVID-19 continued yesterday when outspoken reggae artiste Tanya Stephens questioned the relevance of not allowing people to decide for themselves what they wish to take to reduce symptoms.
Dr. Safranek aligns his message with groups such as the Front Line COVID-19 Critical Care Alliance (FLCCC) who emphasize the early-onset treatment of the viral disease can make a difference between life and death.
Jamaica’s Minister of Health and Wellness recently signed the import permit to allow stocks of Ivermectin into Jamaica. This comes after rising cases due to the COVID-19 Delta variant and increasing public pressure. Supplies of the generic, anti-parasitic drug will come from Edenbridge Pharmaceuticals in New Jersey and be distributed by LASCO Pharmaceuticals in Jamaica. In general, doctors are pleased about having Ivermectin as an option.
It’s all so cruel and unnecessary. With or without Professor Skerritt, if doctors prescribed ivermectin therapy for every person who tests positive, and wants it, and for their close contacts, the Delta wave would wash away. Offer it to the vaccine-hesitant and anyone seeking protection until they were vaccinated, and we could reopen our borders. How apposite that the escape route out of our pandemic prison could be as Aussie as Vegemite.
We believe that the Medical Products Agency should follow the example of the Czech Republic, Slovakia and several other countries and approve ivermectin as treatment for covid-19
The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”
Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post-COVID-19 syndrome (also known as long COVID) via an anti-inflammatory action.
Dr. Vladimir Zelenko talks with author John Leake about treating his patients for Covid-19 and then sharing his insight with the White House. In spite of (or because of) President Trump’s initial embrace of Dr. Zelenko’s treatment protocol, government agencies such as the NIH and FDA first dismissed it, and then prevented public access to its key ingredient, hydroxychloroquine. This deliberate suppression of a life saving medication led to the preventable deaths of hundreds of thousands of Americans.
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
The Roman/Hernandez meta-analysis comes at a politically contentious moment. Their language and behavior appear political. Their work is error-laden, takes research out of its true context, uses numbers that don’t seem to come from the actual studies, chooses papers testing ivermectin under the least favorable circumstances, gives unexplained and inappropriate weights to the small amount of data that stands as outliers to the bigger picture, and still drives a conclusion of “don’t use this” from a massive average mortality reduction that did not quite reach statistical significance. At the same time the authors consistently complain about the “low quality of evidence” represented by the studies they do and do not include, nearly all of which I would describe as produced by higher quality scientists who can at least tally numbers correctly.
Those who design the trials and control the data also control the outcome. So this system of industry-led trials needs to be put to an end.
For months, India’s national authorities have authorized ivermectin as a regimen to be included targeting COVID-19 yet this authorization was then removed due in part to both internal and external political pressure. Now the world’s fourth most populous nation’s regulatory authority has authorised ivermectin’s use in a major breakthrough for the drug’s role in the COVID-19 pandemic.
Oxford University is going to investigate the effectiveness of ivermectin as a COVID-19 treatment. Emeritus Professor Robert Clancy, an immunologist at the University of Newcastle, tells Paul Turton that he believes they’ll find the drug useful, and that it will become part of our coronavirus response.
Source: Rounding The Earth Author: Mathew Crawford Since sometime last summer, I’ve paid (increasing) attention to much of the rapidly growing body of evidence that ivermectin (IVM) effectively treats SARS-CoV-2 and COVID-19. While I decided some months ago that I believe IVM almost surely works as a treatment and could effectively end the pandemic, the strange consistency […]
Pointing out the drug’s safety, this German physician suggested that where ivermectin (Driponin in Germany) is in use, the incidence of COVID-19 goes down.
Large reductions in Covid-19 deaths are possible using ivermectin.
Using ivermectin early may reduce the numbers progressing to severe disease.
Ivermectin is low cost.
Dr Patrick Phillips MD regarding Covid-19 Treatment… “Seeing what’s happened with the Ontario Science Table, not recommending Ivermectin, even recommending against Vitamin D, which I think is unthinkable, because the harm is none. This is a natural substance and they’re telling us NOT to give this to these patients despite mortality benefit. I know there is something going wrong and I knew I needed to speak out no matter what the college does to my license.”
The authors concluded based on this extensive review that ivermectin actually reduced the risk of death compared with no ivermectin (average risk ratio 0.38, 95% CI 0.19-0.73; n = 2438; I2 = 49%; moderate-certainty evidence).
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
In absolute honesty, I don’t think vaccines are even necessary. Why are they not necessary? Well that’s because there are at least four or five safe and effective medicines and their presence has been suppressed and hidden from the public, so they’re not really necessary.
Ivermectin is on the WHO’s list of essential medicines and has a high safety profile with more than 3.7 billion doses having been distributed in more than 30 years.
This is pulled straight from the same playbook as the propaganda against HCQ. Even if you’re not sure that one or both of these medicines is effective despite uniformly positive results when applied as early treatment, you should at least recognize the pattern, scratch your head, and question whether there is…maybe…just possibly some perverse incentive like power or profit from vaccines driving this absurdity.
There are so many ways to attack this virus, so we’ll move forward with an argument that SARS-CoV-2 is far easier to handle than its public image suggests.
In a letter dated the 23rd of April, 2021, four Guest Editors publicly resigned from the journal Frontiers in Pharmacology. Professor Maria Cristina Albertini, Professor Piero Sestili, Dr. Robert Malone, and Dr. Howard Haimes stepped down in protest over executive decisions not to publish two papers showing positive results of various agents in protecting against or treating COVID-19.
Bret, Pierre, Heather, and a large number of internet pundits make a great case that suppression of ivermectin is a large, gross, and inhumane crime. However, this is not the “crime of the century”. The crime of the century is far larger, or rather more systemic.
Just as fast as new cases materialized so has the decline thanks in part to a coordinated public health strategy that includes proactive testing, home visits, and medication kits that include ivermectin.
With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19.
The kits distributed included ivermectin, aspirin and paracetamol. Between the end of November 2020 and the end of January 2021, more than 200,000 people tested positive for COVID, and of these, nearly 80,000 used the ivermectin kits. Results showed up to 76% reduction in hospitalization in the group that was taking ivermectin.